Product Information
BEYAZ 28 TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $8.2939 per EA under NDC 50419040703. Its NADAC has been published 601 times since Nov 28, 2013.
BEYAZ 28 TABLET
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calciumManufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419040703
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022532On Market Since
10/7/2010
Price Statistics
The NADAC for BEYAZ 28 TABLET has been published 601 times since Nov 28, 2013, and over the history we have for it it has risen 157.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.2939 per EA |
|---|---|
| All-time high | $8.3627 (Dec 11, 2024) |
| All-time low | $3.2230 (Nov 28, 2013) |
| 52-week high | $8.3517 |
| 52-week low | $8.2885 |
| Median price | $7.2017 |
| Average price | $6.7201 |
| Largest weekly change | +9.9% (Feb 18, 2015) |
| Weeks tracked | 601 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BEYAZ 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BEYAZ 28 TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $8.2939 per EA (NDC 50419040703), effective Jun 24, 2026.
How has the price of BEYAZ 28 TABLET changed over time?
Over the history we have for it, the NADAC for BEYAZ 28 TABLET has risen 157.3%. It has been tracked across 601 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BEYAZ 28 TABLET?
Since Nov 28, 2013, the NADAC for BEYAZ 28 TABLET has ranged from a low of $3.2230 (Nov 28, 2013) to a high of $8.3627 (Dec 11, 2024), with a median of $7.2017 per EA.
Are there cheaper alternatives to BEYAZ 28 TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROSP-EE-LEVOMEF 3-0.02-0.451, is $1.5617 per EA — about 81% below BEYAZ 28 TABLET.
Who manufactures BEYAZ 28 TABLET?
BEYAZ 28 TABLET (NDC 50419040703) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification